Cargando…
Targeted Therapy in Hepatocellular Carcinoma
Hepatocellular carcinoma (HCC) is one of the commonest cancers worldwide, as well as a common cause of cancer-related death. HCC frequently occurs in the setting of a diseased cirrhotic liver and many patients present at an advanced stage of disease. Together with a poor functional status, this ofte...
Autores principales: | Chua, Clarinda W. L., Choo, Su Pin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE-Hindawi Access to Research
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3170762/ https://www.ncbi.nlm.nih.gov/pubmed/21994852 http://dx.doi.org/10.4061/2011/348297 |
Ejemplares similares
-
Rationale of Immunotherapy in Hepatocellular Carcinoma and Its Potential Biomarkers
por: Tai, David, et al.
Publicado: (2019) -
Clinical Development of c-MET Inhibition in Hepatocellular Carcinoma
por: Lee, Joycelyn J. X., et al.
Publicado: (2015) -
Targeted therapy for hepatocellular carcinoma
por: Huang, Ao, et al.
Publicado: (2020) -
The advanced development of molecular targeted therapy for hepatocellular carcinoma
por: Yan, Tao, et al.
Publicado: (2022) -
A Surgical Perspective on Targeted Therapy of Hepatocellular Carcinoma
por: Faltermeier, Claire, et al.
Publicado: (2015)